Asthma | COPD | ILD
Chronic Disease Management
Our Solution
At electronRx, we are dedicated to improving the lives of people with respiratory conditions through the use of advanced digital technologies that can track and measure changes in lung function. Working closely with leading respiratory and clinical experts, we have developed a comprehensive overview of key respiratory conditions, including asthma, COPD, and ILD. For each condition, we examine current treatment approaches, highlight ongoing challenges, and explore how our lungDx technology can play a role in enhancing patient care.
"This book is both a clinical deep dive and a strategic blueprint. It reflects our mission to digitise the invisible—to capture, interpret, and act on the physiological signals hidden in everyday behaviour.
We’re not building generic tools; we’re building tailored solutions for complex, under-monitored conditions."
Dr Bipin Patel
CEO and Founder
Our Purpose
Across the globe, millions of people are living with respiratory disease. 454 million people with respiratory conditions need better care*. For many, it’s a daily struggle: breathlessness, unpredictability, anxiety. For healthcare systems, it’s an ongoing crisis: missed diagnoses, uncontrolled symptoms, and rising costs.
We’re not here to generate dashboards. We’re here to deliver impact. Pharma partners are leveraging lungDx to accelerate trials, validate endpoints with real-world evidence, and de-risk pipeline decisions. Payers are recognising the downstream cost savings from earlier detection and better control. Providers are seeing the value in tools that go beyond population averages to deliver personalised care.
*Institute for Health Metrics and Evaluation
